HISTOGENICS CORP Business Operations Contracts & Agreements
13 Contracts & Agreements
- Development Agreements (2 contracts)
- MOUs (1)
- Sales Agreements (4)
- Supply Agreements (3)
- Termination Agreements (1)
- Voting Agreements (2)
- At Market Issuance Sales Agreement, dated June 10, 2022, by and among Ocugen, Inc., Cantor Fitzgerald & Co., Mizuho Securities USA LLC, H.C. Wainwright & Co., LLC, Roth Capital... (Filed With SEC on June 10, 2022)
- Second Amendment to Co-Development, Supply and Commercialization Agreement, dated as of April 15, 2022, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on May 6, 2022)
- Development and Commercial Supply Agreement, dated September 29, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on November 9, 2021)
- First Amendment to Co-Development, Supply and Commercialization Agreement, dated as of May 29, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on August 6, 2021)
- Co-Development, Supply and Commercialization Agreement, dated as of January 31, 2021, by and between the Registrant and Bharat Biotech International Limited (Filed With SEC on May 7, 2021)
- At Market Issuance Sales Agreement, dated August 14, 2020, by and among Ocugen, Inc., Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc (Filed With SEC on August 17, 2020)
- Controlled Equity OfferingSM Sales Agreement, dated June 12, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on June 12, 2020)
- Controlled Equity OfferingSM Sales Agreement, dated May 8, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on May 8, 2020)
- Letter of Understanding, dated November 8, 2017, between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)
- Form of Histogenics Voting Agreement, dated April 5, 2019, by and between Ocugen, Histogenics and each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)
- Form of Ocugen Voting Agreement, dated April 5, 2019, by and between Histogenics, Ocugen and each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)
- Mutual Termination and Release Agreement dated December 21, 2018, between Histogenics Corporation and Intrexon Corporation (Filed With SEC on December 21, 2018)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT TO LICENCE AGREEMENT Made and entered in to this 23rd day of March 2010 By and between YEDARESEARCH AND DEVELOPMENT COMPANY LIMITED (Filed With SEC on October 7, 2014)
